Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 2/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | MME | P08473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | BACE1 | P56817 | 3/20 | 0.44 |
| ▸ | CTSD | P07339 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LAP3 | P28838 | 3/20 | 0.43 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.43 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29447329 | 0.97 | ECE1 (0.54) | ECE1SLC7A5MMEALDH1A1BACE1 | |
| SCHEMBL29538126 | 0.95 | ECE1 (0.52) | ECE1SLC7A5MMEALDH1A1BACE1 | |
| SCHEMBL30507894 | 0.94 | ECE1 (0.51) | ECE1SLC7A5MMEBACE1CTSD | |
| SCHEMBL29883560 | 0.93 | ECE1 (0.50) | ECE1SLC7A5MMEBACE1CTSD | |
| SCHEMBL9657142 | 0.90 | ALDH1A1 (0.53) | ECE1SLC7A5MMEALDH1A1MAPT | |
| SCHEMBL31073604 | 0.90 | MME (0.55) | ECE1SLC7A5MMEBACE1CTSD | |
| Hydrochloric Acid SCHEMBL23404094 | 0.89 | ALDH1A1 (0.51) | ECE1SLC7A5MMEALDH1A1MAPT | |
| SCHEMBL30956311 | 0.88 | BACE1 (0.48) | ECE1MMEALDH1A1BACE1CTSD | |
| SCHEMBL31752207 | 0.88 | MME (0.55) | SLC7A5MMEALDH1A1MAPTLAP3 | |
| SCHEMBL7822916 | 0.88 | MME (0.55) | SLC7A5MMEALDH1A1MAPTLAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4329827-A1 | TARGETING SYSTEM FOR CANCER COMPRISING A RADIOISOTOPE | Alphathera AG (CH) | 2024-03-06 | — | — | EP | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| WO-2022240959-A2 | COMPOSITIONS AND METHODS FOR TREATING AND/OR IDENTIFYING AN AGENT FOR TREATING HIV-1 INFECTIONS | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2022-11-17 | — | — | WO | claimed |
| WO-2022231424-A1 | TARGETING SYSTEM FOR CANCER COMPRISING A RADIOISOTOPE | ALPHATHERA AG (CH) | 2022-11-03 | — | — | WO | claimed |
| WO-2022148418-A1 | PHARMACEUTICAL COMPOSITION CAPABLE OF BEING DELIVERED BY METERED DOSE INHALER | 江苏恒瑞医药股份有限公司 | 2022-07-14 | — | — | WO | claimed |
| US-20250295713-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES | DERMBIONT, INC. | 2025-09-25 | — | — | US | disclosed |
| WO-2025109003-A1 | P-CADHERIN LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-05-30 | — | — | WO | disclosed |
| CN-120005928-A | Dynamic regulation and control system, strain, construction method of strain and application of strain in microbial fuel cell | 天津科技大学 | 2025-05-16 | — | — | CN | disclosed |
| CN-119776332-A | Enzymatic preparation process of histamine dihydrochloride | 上海瀚鸿科技股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-118308367-B | Mulberry MaWRKY gene and application thereof | 成都师范学院 | 2024-11-29 | — | — | CN | disclosed |
| CN-118909996-A | Galactosyltransferase mutant and application thereof in preparation of flavonoid compounds | 浙江大学 | 2024-11-08 | — | — | CN | disclosed |
| CN-118853640-A | Carbapenem drug-resistant gene and application thereof | 郑州大学 | 2024-10-29 | — | — | CN | disclosed |
| CN-113292508-B | Synthetic method of cyclic dipeptide containing asparagine or glutamine | 陕西慧康生物科技有限责任公司 | 2022-09-27 | — | — | CN | disclosed |
| WO-2022136555-A9 | IMPROVED CD30 TARGETING ANTIBODY DRUG CONJUGATES AND USES THEREOF | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) | 2022-09-22 | — | — | WO | disclosed |
| CN-113388620-B | FcCGA 1 gene related to citrus disease resistance, primer pair, silencing vector and application | 赣南师范大学 | 2022-08-26 | — | — | CN | disclosed |
| US-20220259265-A1 | Inhibitors and Use Thereof in Cancer Treatment | THE UNIVERSITY OF SYDNEY (AU) | 2022-08-18 | — | — | US | disclosed |
| WO-2022148418-A1 | PHARMACEUTICAL COMPOSITION CAPABLE OF BEING DELIVERED BY METERED DOSE INHALER | 江苏恒瑞医药股份有限公司 | 2022-07-14 | — | — | WO | disclosed |
| WO-2022138957-A1 | METHOD FOR PRODUCING LIPIDIC PEPTIDE | 日産化学株式会社 | 2022-06-30 | — | — | WO | disclosed |
| WO-2022138953-A1 | METHOD FOR PRODUCING LIPID PEPTIDE | 日産化学株式会社 | 2022-06-30 | — | — | WO | disclosed |
| US-20220160617-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES | DERMBIONT, INC. | 2022-05-26 | — | — | US | disclosed |